SEATTLE--(BUSINESS WIRE)--[Attorney Advertising] Keller Rohrback L.L.P. is investigating claims that a recent price hike for the drug Daraprim, a treatment for toxoplasmosis, caused worsening of infection for some patients due to lapses in treatment. On August 10, 2015, Turing Pharmaceuticals L.L.C. purchased the rights to market the drug...
More...
